Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianbai paste for prevention and treatment of acute radiodermatitis
ChiCTR1800018939Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Lianbai paste in acute radiodermatitis (ARD) (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Grade 3/4 acute radiodermatitis. Started Nov 2018; status: recruiting.
02
Drugs
Lianbai paste
03
Conditions
acute radiodermatitis (ARD)
Beyond the preview
Go deeper on ChiCTR1800018939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018939.